Fulvestrant
ICR-CTSU/2015/10056
Phase 2 small_molecule active
Quick answer
Fulvestrant for Advanced Breast Cancer is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Advanced Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active